(PROJECT 3) Project 3 focuses on the pleiotropic damage response known as cellular senescence. The senescence response is an essentially permanent arrest of cell proliferation, accompanied by phenotypic changes, including the development of a senescence-associated secretory phenotype (SASP). The SASP entails the robust expression and secretion of a suite of pro-inflammatory cytokines, chemokines, growth factors and proteases. We have now firmly established that the SASP is a response to genomic/epigenomic damage, and that it can profoundly alter tissue microenvironments and promote both degenerative and hyperplastic phenotypes associated with aging. In this renewal application, we will use human and mouse cell cultures and mouse models to critically determine the role of cellular senescence in damage-induced aging phenotypes, and more thoroughly explore the costs and benefits of the senescence response in the context of aging. We will also determine the role of longevity mediators that have been and will be studied within the PPG in modulating various senescent cell phenotypes.
Our specific aims are designed to answer the following questions: To what extent and under which circumstances do senescent cells contribute to aging phenotypes? To what extent do the longevity-associated genes studied in the PPG alter the phenotype(s) of senescent cells? And to what extent and under what circumstances do senescent cells benefit the organism, specifically by promoting wound healing? Our proposed experiments will provide a critical analysis of the extent to which senescent cells drive aging phenotypes, important information on how senescent phenotypes are regulated, and insights into novel benefits of the senescence response. In addition to generating important basic knowledge, the experiments will also provide a framework for developing and understanding potential interventions into aging phenotypes.

Public Health Relevance

(PROJECT 3) Damage to the genome is thought to cause many of the manifestations and diseases of aging. This project will determine how the cellular damage response known as cellular senescence drives aging, and will provide proof of principle that eliminating senescent cells can prevent or reverse damage-induced aging phenotypes.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
2P01AG017242-17A1
Application #
8742954
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2014-09-30
Budget End
2015-04-30
Support Year
17
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
City
Bronx
State
NY
Country
United States
Zip Code
Lau, Cia-Hin; Suh, Yousin (2018) In vivo epigenome editing and transcriptional modulation using CRISPR technology. Transgenic Res 27:489-509
Wiley, Christopher D; Schaum, Nicholas; Alimirah, Fatouma et al. (2018) Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype. Sci Rep 8:2410
Quispe-Tintaya, Wilber; Lee, Moonsook; Dong, Xiao et al. (2018) Bleomycin-induced genome structural variations in normal, non-tumor cells. Sci Rep 8:16523
Hébert, Jean M; Vijg, Jan (2018) Cell Replacement to Reverse Brain Aging: Challenges, Pitfalls, and Opportunities. Trends Neurosci 41:267-279
Yu, Bo; Dong, Xiao; Gravina, Silvia et al. (2017) Genome-wide, Single-Cell DNA Methylomics Reveals Increased Non-CpG Methylation during Human Oocyte Maturation. Stem Cell Reports 9:397-407
Vijg, Jan; Dong, Xiao; Zhang, Lei (2017) A high-fidelity method for genomic sequencing of single somatic cells reveals a very high mutational burden. Exp Biol Med (Maywood) 242:1318-1324
Ogrodnik, Mikolaj; Miwa, Satomi; Tchkonia, Tamar et al. (2017) Cellular senescence drives age-dependent hepatic steatosis. Nat Commun 8:15691
Dong, Xiao; Zhang, Lei; Milholland, Brandon et al. (2017) Accurate identification of single-nucleotide variants in whole-genome-amplified single cells. Nat Methods 14:491-493
Olivieri, Fabiola; Capri, Miriam; Bonafè, Massimiliano et al. (2017) Circulating miRNAs and miRNA shuttles as biomarkers: Perspective trajectories of healthy and unhealthy aging. Mech Ageing Dev 165:162-170
Perrott, Kevin M; Wiley, Christopher D; Desprez, Pierre-Yves et al. (2017) Apigenin suppresses the senescence-associated secretory phenotype and paracrine effects on breast cancer cells. Geroscience 39:161-173

Showing the most recent 10 out of 253 publications